EyePoint Pharmaceuticals Inc (PSDV):企業の財務・戦略的SWOT分析

◆英語タイトル:EyePoint Pharmaceuticals Inc (PSDV) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME3119FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
EyePoint Pharmaceuticals Inc (EyePoint), formerly pSivida Corp, is a biopharmaceutical company that provides development of miniaturized, sustained-release drug delivery products and technologies. The company offers products such as iluvien, retisert and durasert, among others. EyePoint durasert is an injectable, miniaturized, sustained-release drug delivery system, used for the treatment of chronic diseases of the back of the eye. The company’s iluvien is an injectable, non-erodible, intravitreal implant for the treatment of DME. EyePoint provides drug delivery products and technologies to treat serious, debilitating diseases of the eye that can lead to blindness. The company operates in the US and the UK. EyePoint is headquartered in Watertown, Massachusetts, the US.

EyePoint Pharmaceuticals Inc Key Recent Developments

Feb 25,2021: EyePoint Pharmaceuticals to Report Fourth Quarter and Full Year 2020 Financial Results on March 4, 2021
Oct 08,2020: EyePoint Pharmaceuticals announces amendment to CRG debt facility modifying 2020 and 2021 revenue covenants
Oct 07,2020: EyePoint Pharmaceuticals announces preliminary net product revenue for third quarter 2020
Aug 05,2020: EyePoint Pharmaceuticals reports second quarter 2020 financial results and highlights recent corporate developments
Jul 13,2020: EyePoint Pharmaceuticals expands executive leadership team with the appointment of Jay S. Duker, M.D., as chief strategic scientific officer

This comprehensive SWOT profile of EyePoint Pharmaceuticals Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of EyePoint Pharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

EyePoint Pharmaceuticals Inc – Key Information
EyePoint Pharmaceuticals Inc – Overview
EyePoint Pharmaceuticals Inc – Key Employees
EyePoint Pharmaceuticals Inc – Key Employee Biographies
EyePoint Pharmaceuticals Inc – Key Operational Heads
EyePoint Pharmaceuticals Inc – Major Products and Services
EyePoint Pharmaceuticals Inc – History
EyePoint Pharmaceuticals Inc – Company Statement
EyePoint Pharmaceuticals Inc – Locations And Subsidiaries
EyePoint Pharmaceuticals Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

EyePoint Pharmaceuticals Inc – Business Description
EyePoint Pharmaceuticals Inc – Corporate Strategy
EyePoint Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
EyePoint Pharmaceuticals Inc – Strengths
EyePoint Pharmaceuticals Inc – Weaknesses
EyePoint Pharmaceuticals Inc – Opportunities
EyePoint Pharmaceuticals Inc – Threats
EyePoint Pharmaceuticals Inc – Key Competitors

Section 3 – Company Financial Performance Charts

EyePoint Pharmaceuticals Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

EyePoint Pharmaceuticals Inc, Key Information
EyePoint Pharmaceuticals Inc, Key Ratios
EyePoint Pharmaceuticals Inc, Share Data
EyePoint Pharmaceuticals Inc, Major Products and Services
EyePoint Pharmaceuticals Inc, History
EyePoint Pharmaceuticals Inc, Key Employees
EyePoint Pharmaceuticals Inc, Key Employee Biographies
EyePoint Pharmaceuticals Inc, Key Operational Heads
EyePoint Pharmaceuticals Inc, Other Locations
EyePoint Pharmaceuticals Inc, Subsidiaries
EyePoint Pharmaceuticals Inc, Key Competitors
EyePoint Pharmaceuticals Inc, SWOT Analysis
EyePoint Pharmaceuticals Inc, Ratios based on current share price
EyePoint Pharmaceuticals Inc, Annual Ratios
EyePoint Pharmaceuticals Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[EyePoint Pharmaceuticals Inc (PSDV):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pharmstandard:企業の戦略的SWOT分析
    Pharmstandard - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • University of South Florida-製薬・医療分野:企業M&A・提携分析
    Summary University of South Florida (USF) is an educational university that offers undergraduate, graduate, specialist and doctoral level degrees. The university offers degrees in various fields including accounting, advertising, Africana studies, American studies, anthropology, applied science, mar …
  • Mayo Clinic:医療機器:M&Aディール及び事業提携情報
    Summary Mayo Clinic (Mayo) is a not-for-profit medical practice and medical research organization. It provides comprehensive medical facilities and programs related to patient care services, research and medical education. It offers specialized medical care with medical departments and centers in mo …
  • ManTech International Corp (MANT):企業の財務・戦略的SWOT分析
    ManTech International Corp (MANT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Whirlpool Of India Limited:企業の戦略・SWOT・財務情報
    Whirlpool Of India Limited - Strategy, SWOT and Corporate Finance Report Summary Whirlpool Of India Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Vstecs Holdings Ltd
    Vstecs Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Vstecs Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Capitol Federal Financial, Inc:企業の戦略・SWOT・財務情報
    Capitol Federal Financial, Inc - Strategy, SWOT and Corporate Finance Report Summary Capitol Federal Financial, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • China Development Bank:企業の戦略・SWOT・財務分析
    China Development Bank - Strategy, SWOT and Corporate Finance Report Summary China Development Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Surge Energy Inc (SGY):企業の財務・戦略的SWOT分析
    Summary Surge Energy Inc (Surge) is an oil and gas company that offers acquisitions, exploration and production of crude oil and natural gas reserves. The company provides risk management and risk development drilling services. Its oil and natural gas producing properties include Shaunavon and Dodsl …
  • Sherman & Howard LLC:企業の戦略的SWOT分析
    Sherman & Howard LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Specialist Computer Centres Plc:企業の戦略・SWOT・財務情報
    Specialist Computer Centres Plc - Strategy, SWOT and Corporate Finance Report Summary Specialist Computer Centres Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • BowLeven plc (BLVN):企業の財務・戦略的SWOT分析
    Summary BowLeven Plc (BowLeven) is an independent oil and gas exploration and production company. The company’s business activities include acquisition, exploration, and development of oil and gas properties. It holds equity interests in offshore and onshore exploration acreage in Cameroon and Gabon …
  • Xilinx, Inc.:企業の戦略・SWOT・財務情報
    Xilinx, Inc. - Strategy, SWOT and Corporate Finance Report Summary Xilinx, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Sisaf Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Sisaf Ltd (Sisaf) is a drug delivery company which designs and develops topical delivery systems for cosmetic, medical, and skin care applications. The company manufactures and markets products and drug delivery solutions using ProSilic, a nano-silicon technology platform. It offers ProSilli …
  • Continental Grain Co:企業の戦略的SWOT分析
    Continental Grain Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Vornado Realty Trust:企業のM&A・事業提携・投資動向
    Vornado Realty Trust - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Vornado Realty Trust Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Hanwha Q CELLS Co Ltd (HQCL):企業の財務・戦略的SWOT分析
    Hanwha Q CELLS Co Ltd (HQCL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • SignPath Pharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary SignPath Pharma Inc (SignPath) is a developer of therapeutics based on its pure synthesized curcumin compounds. The company’s curcumin compounds acts as an anti-oxidant, anti-inflammatory and anti-cell recycling agent. It develops curcumin based products in different intravenous nanoparticle …
  • Nufarm Limited (NUF):企業の財務・戦略的SWOT分析
    Nufarm Limited (NUF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • InterOil Corporation (IOC)-石油・ガス分野:企業M&A・提携分析
    Summary InterOil Corporation (InterOil) is an independent oil and gas company that carries out acquisition, exploration and development of oil and gas assets. It principally focuses on liquefied natural gas (LNG) projects in Papua New Guinea (PNG). It has several exploration licenses in the prospect …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆